Uterine Diseases
Conditions
Brief summary
This is a prospective, randomized, single-center, observational clinical trial at the Department of Women's Health of the University Clinic Tübingen. Four hundred patients affected by uterine diseases that undergo treatment with robotic assisted laparoscopic procedures using the Da Vinci Robotic Surgical System (200 patients) or conventional laparoscopic surgery (200 patients) will be recruited. In addition retrospective data of 200 patients that underwent conventional laparoscopic surgery in the past will be documented. At the end of patient recruitment, surgical procedure times, the technical limits encountered, estimated blood loss, intra- and post-operative complications and the percentage of conversions from the robotic assisted treatment /conventional laparoscopic surgery to multiple access and/or to a laparotomic (open) approach will be documented.
Interventions
PROCEDURElaparoscopic surgery
patients affected by uterine diseases that undergo treatment
Sponsors
University Hospital Tuebingen
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* age ≥18 years * BMI ≤40 kg/m2 * indication for hysterectomy for benign disease or prophylactic surgery due to hereditary cancer * indication for radical hysterectomy and/or pelvic-/para-aortic (sentinel-node) lymphadenectomy for cervical cancer * indication for modified radical hysterectomy and/or pelvic-/para-aortic (sentinel-node) lymphadenectomy for endometrial cancer * size of uterus and vagina allows for retrieval by the vaginal route in cancer patients * written informed consent
Exclusion criteria
* known extensive intra-abdominal adhesions * anaesthesiological contraindications to laparoscopy * women with pacemaker or other implants where electrosurgery is to be avoided * women with known defects of the hemostasis * pregnancy * other internal or anatomical criteria that preclude a minimal invasive approach * inability to understand patient information
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| operative time | 60 minutes | (minutes from first incision to skin closure) |
| time under narcosis | 60 minutes | — |
| console time | 60 minutes | — |
| estimated blood loss (milliliters) | 60 minutes | using the following formula: ((Hemoglobin concentration preoperative (g/l)) - (Hemoglobin 1st day postoperative (g/l)))/((Hemoglobin preoperative (g/l)) - (Hemoglobin 1st day postoperative (g/l)))/2) × 1000 |
| conversion to other surgical procedures | 60 minutes | — |
| time to discharge | 60 minutes | — |
| intraoperative complications | 60 minutes | occurring during the surgical procedure |
| perioperative complications | 24 hours | occurring less than 24h after the surgical procedure, according to the Clavien-Dindo classification of surgical complications |
| postoperative complications | 6 months | occurring more than 24h after the surgical procedure up to 6 months after surgical procedure, according to the Clavien-Dindo classification of surgical complications |
| German version of the Short Form-36health survey questionnaire Medical Outcomes Trust | 3 and 6 months | Medical Outcomes Trust: SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting. |
| German version of the female sexual function index (FSFI) questionnaire | 3 and 6 months | female sexual function index: a multidimensional self-report instrument for the assessment of female sexual function |
Countries
Germany
Outcome results
None listed